Age-related macular degeneration (AMD) is the leading cause of severe, permanent visual impairment and blindness in people over the age of 60. The World Health Organization (WHO) estimates that 8.7% of global blindness is caused by AMD. The financial burden is enormous with global costs of visual impairment reaching US $343 billion. In 2020, estimated 15.2 million people aged over 50 years were blind worldwide, and an additional 78.8 million had moderate-tosevere vision impairment due to cataracts. 1 Cataract and age-related macular degeneration are common causes of decreased vision, causing visual impairment that often occurs simultaneously. Although modern cataract surgery is a safe and effective treatment for cataract-induced visual loss, some ophthalmologists have had fear in the past that surgery could worsen macular degeneration. This has been disproven by various studies in the past. 2,3 It was shown that Quality of Life (QOL) benefits were predominant in the group that underwent cataract surgery and that there was no increased risk of progression of maculopathy. 4 Recent clinical and scientific evidence does not find cataract surgery to cause or worsen AMD. 5 Nevertheless, the reduced prognosis and possible effects should be discussed in detail with the patients already preoperatively.The purpose of low-vision rehabilitation is to allow people to resume performing activities of daily living skills (ADLs) and achieving self-autonomy through improved quality of life (QOL), with reading being one of the most important tasks. 6 This is achieved by special training (neuroadaptation) in the use of assistive technology by prescribing appropriate devices, which range from basic magnifiers to high-magnification video-magnifiers to smartphones and tablets to virtual and augmented reality tools. 7 Intraocular vision-improving devices, such as the Implantable Miniature Telescopes (IMT) and intraocular lens (IOL) implants, may be superior to external devices for improving vision in patients with AMD because they provide a more intuitive technology with respect to head motion, vestibular ocular reflex adaptation, and monocular depth perception. [8][9][10][11] However, challenges may remain, for some patients, with adaptation to new bi-ocular vision status.In the past, it has been shown that cost and rehabilitation time are factors in patient management with intraocular devices. Patients require much more intensive care both pre-and post-implantation, including additional controls and evaluations. Technological improvements and developments have made these implants safer and the procedure itself less dangerous with reduced post-operative sequelae. Therefore, it has become apparent that the limiting factor is not so much of the actual surgery but rather the patient selection and rehabilitation process. It has been shown that these cases are complex and should never be routine interventions.We were also able to show in a multicenter study that testing with conventional visual acuity tests, such as the standard Snellen and...